Loading…
Cencora, Inc. is projected to rise to $391.52 by 2027, a +23% move from its current price of $319.58. COR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $315.39 | $319.64 | $323.96 | +0.02% |
| Aug 1 | $313.70 | $319.71 | $325.83 | +0.04% |
| Aug 2 | $312.43 | $319.77 | $327.29 | +0.06% |
| Aug 3 | $311.37 | $319.84 | $328.53 | +0.08% |
| Aug 4 | $310.45 | $319.90 | $329.64 | +0.10% |
| Aug 5 | $309.62 | $319.96 | $330.65 | +0.12% |
| Aug 6 | $308.87 | $320.03 | $331.58 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $308.87 | $320.03 | $331.58 | +0.14% |
| Week 2 | $304.79 | $320.47 | $336.96 | +0.28% |
| Week 3 | $301.80 | $320.92 | $341.26 | +0.42% |
| Week 4 | $299.36 | $321.37 | $345.00 | +0.56% |
| Week 5 | $297.28 | $321.82 | $348.39 | +0.70% |
| Week 6 | $295.45 | $322.27 | $351.53 | +0.84% |
| Week 7 | $293.81 | $322.72 | $354.48 | +0.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. It operates in the healthcare sector with two segments focused on pharmaceuticals, distribution, and related services across diverse customers.
Its U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; it also distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products, and provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.
Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.
Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Cencora, Inc. (COR) is a healthcare company that distributes pharmaceutical products and related services in the United States and internationally.
The current price is $319.58, with a market capitalization of $62.18B and a market rank of 253.
Forecast highlights show a path of growth from 2026 onward, with the 2026 average price at $319.58 and a bullish trajectory through 2050. Key milestones include 2027 average $391.52, 2028 $437.13, 2029 $461.52, 2030 $519.42, 2040 $1,483.66, and 2050 $2,712.27; projected ROIs rise from 0% in 2026 to 62.5% in 2030, 364.3% in 2040, and 748.7% in 2050.
A major floor 20.9% below — a decisive break under it would weaken the trend.
The nearest floor, 15.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 5.7% above — clearing it would confirm fresh momentum.
Key COR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $304.77 | Buy | $306.12 | Buy |
| MA 10 | $304.47 | Buy | $304.16 | Buy |
| MA 20 | $299.95 | Buy | $299.53 | Buy |
| MA 50 | $283.07 | Buy | $294.37 | Buy |
| MA 100 | $301.37 | Buy | $301.02 | Buy |
| MA 200 | $324.53 | Sell | $306.88 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.75 | Neutral |
| Stoch RSI (14) | 44.61 | Neutral |
| CCI (20) | 108.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 0.51 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 13.37 | Buy |
| Ultimate (7,14,28) | 69.06 | Neutral |
| Momentum (10) | 7.71 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 305.04 | Buy |
| ADX (14) | 22.04 | Buy |
| ATR (14) | 4.00 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, indicating steady bullish momentum without overbought conditions. The price is above the 50-day simple moving average (SMA) of $283.07 and below the 200-day SMA of $324.53, suggesting a mixed near-term trend.
Support sits at $271.28 and resistance at $311.15. The 30-day price range runs from $292.54 to $349.11, signaling ongoing volatility within that band. Annualized volatility stands at 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $252.74 | $319.58 | $419.98 | 0% | Neutral | |
| $320.98 | $391.52 | $499.06 | +23% | Bullish | |
| $351.69 | $437.13 | $572.48 | +37% | Bullish | |
| $365.62 | $461.52 | $617.41 | +44% | Bullish | |
| $405.98 | $519.42 | $707.47 | +63% | Bullish | |
| $478.53 | $619.75 | $857.54 | +94% | Bullish | |
| $538.75 | $705.66 | $990.37 | +121% | Bullish | |
| $614.68 | $813.60 | $1,156.71 | +155% | Bullish | |
| $662.89 | $886.17 | $1,275.00 | +177% | Bullish | |
| $676.09 | $912.38 | $1,327.37 | +185% | Bullish | |
| $1,054.01 | $1,483.66 | $2,262.25 | +364% | Bullish | |
| $1,796.48 | $2,712.27 | $4,433.55 | +749% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $252.74 | $319.58 | $373.13 | +0.00% |
| August 2026 | $272.16 | $317.49 | $377.55 | -0.65% |
| September 2026 | $277.43 | $325.45 | $390.58 | +2.51% |
| October 2026 | $285.12 | $335.99 | $406.19 | +3.24% |
| November 2026 | $285.73 | $337.97 | $411.01 | +0.59% |
| December 2026 | $289.41 | $343.48 | $419.98 | +1.63% |
Click any year to see its month-by-month COR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cencora, Inc.'s 2026 outlook centres on $319.58, within a $252.74 to $419.98 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, COR could reach as high as $499.06, with a base case around $391.52 and support toward $320.98 — roughly +23% from $319.58. Momentum favours further upside here.
Expect COR to range from $351.69 to $572.48 through 2028. The $437.13 average target implies a +37% move from current prices. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The COR price prediction for 2029 points to an average of $461.52 (low $365.62, high $617.41) — a potential gain of +44% on today's $319.58. Momentum favours further upside here.
In 2030, COR is projected to trade between $405.98 and $707.47, averaging $519.42 — a potential gain of +63% from today's $319.58. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Cencora, Inc.'s 2031 outlook centres on $619.75, within a $478.53 to $857.54 range. That is up +19% on the projected 2030 average. That marks a +94% change versus current levels. Momentum favours further upside here.
By 2032, COR could reach as high as $990.37, with a base case around $705.66 and support toward $538.75 — roughly +121% from $319.58. Buyers look set to stay in control over this stretch.
Expect COR to range from $614.68 to $1,156.71 through 2033. The $813.60 average target implies a +155% move from current prices. That is up +15% on the projected 2032 average. Momentum favours further upside here.
The COR price prediction for 2034 points to an average of $886.17 (low $662.89, high $1,275.00) — a potential gain of +177% on today's $319.58. Buyers look set to stay in control over this stretch.
In 2035, COR is projected to trade between $676.09 and $1,327.37, averaging $912.38 — a potential gain of +185% from today's $319.58. That is up +3% on the projected 2034 average. Momentum favours further upside here.
Cencora, Inc.'s 2040 outlook centres on $1,483.66, within a $1,054.01 to $2,262.25 range. That is up +63% on the projected 2035 average. That marks a +364% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, COR could reach as high as $4,433.55, with a base case around $2,712.27 and support toward $1,796.48 — roughly +749% from $319.58. Momentum favours further upside here.
Investing $1,000 in COR today (≈ 3.129107 COR) could be worth
$8,486.99
+$7,486.99 (+749%) by 2050 · US Dollar
Based on the average projected COR price of $2,712.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CORwould be worth at today's price.
$1,000 invested in COR on Jul 28, 2025 (≈ 3.49406 COR) would be worth
$1,116.63
+$116.63 (+11.7%) today · 1.12× · US Dollar
Based on a COR entry price of $286.2 vs. today's $319.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $303.99 | $1,051.28 | +5.1% |
| 1 month ago | $286.13 | $1,116.9 | +11.7% |
| 3 months ago | $311.99 | $1,024.33 | +2.4% |
| 6 months ago | $350.54 | $911.68 | -8.8% |
| 1 year ago | $286.2 | $1,116.63 | +11.7% |
| All time (5.0y) ago | $122.73 | $2,603.93 | +160.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COR forecast.
Our base-case forecast reaches $640.00 around 2032.
Implied market cap at $640.00: $124.52B
The multi-year forecast shows bullish sentiment across the horizon, with average prices rising from $319.58 in 2026 to $2,712.27 in 2050. Key milestones include 2027 avg $391.52 (ROI 22.5%), 2028 avg $437.13 (ROI 36.8%), 2029 avg $461.52 (ROI 44.4%), and 2030 avg $519.42 (ROI 62.5%), followed by substantial long-run gains to 2040 avg $1,483.66 (ROI 364.3%) and 2050 avg $2,712.27 (ROI 748.7%).
The 2030 forecast includes a min of $405.98 and a max of $707.47, with bullish sentiment. The 2040 forecast spans a min of $1,054.01 and a max of $2,262.25, with a large increase in average to $1,483.66. The 2050 forecast shows min $1,796.48, max $4,433.55, and an average of $2,712.27, signaling strong long-term upside.
These are estimates and not guarantees. While the outlook is bullish over the long term, there is uncertainty and risk inherent in any forecast, and numbers should be considered as directional guidance rather than a promise of future results.
Tap a question to reveal the answer.
2030 min is $405.98, average is $519.42, and max is $707.47, with a forecasted ROI of 62.5% and bullish sentiment.
The forecast shows bullish sentiment from 2027 onward with substantial long-term upside, including 2030 average of $519.42, 2040 average of $1,483.66, and 2050 average of $2,712.27, yielding ROIs of 62.5%, 364.3%, and 748.7% respectively. These are estimates and not guarantees.
2030 max is $707.47, so $1,000 is not reached by 2030. By 2040, the max forecast is $2,262.25, making a $1,000 level within the forecast range.
Current price is $319.58 and market cap is $62.18B.
RSI14 is 60 (bullish), SMA50 is $283.07, SMA200 is $324.53. Support is $271.28 and resistance is $311.15. The 30-day range runs from $292.54 to $349.11, with annualized volatility of 30%.
Cencora, Inc. Community Discussion
0Share your Cencora, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.